Daily Market Updates: Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts

Earnings

Home›Earnings›Results›Buy the Dip: 4 Stocks the Market Marked Down Too Far A…

Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts

Reported · Written up by our desk · Results

MercadoLibre, Novo Nordisk, Tyler Technologies and Summit Therapeutics trade below recent highs, yet each has earnings or catalysts that could shift sentiment.

← Newer storyTom Lee's Bitmine favors share buybacks to ether purchases as crypto…Older story →Insiders Are Selling These 5 AI Stocks,Should You Worry?

More like this

EarningsInsiders Are Selling These 5 AI Stocks,Should You Worry?

Earnings3 Companies With Room to Pass on Costs to Manage Inflation

EarningsNot All Tech Is Getting Crushed: 5 Names Holding Up Through the AI Sell-Off

EarningsActively Managed ETFs Are Giving In to the Price War,To the Benefit of Investors

EarningsValero’s Windfall Quarter Meets Washington’s Push for Cheaper Diesel

Sources

MarketBeat RatingsBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts

Earnings

Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts

More like this

Sources

Get the close, explained.